Results 41 to 50 of about 25,062 (184)
Candida infections can be serious in intensive care unit (ICU) patients, as Candida is an organism that specially colonizes the digestive system. In immunocompromised patients, treatment is protocolized, but in non-neutropenic patients, it is not well ...
Jordi Ibañez-Nolla, Miquel Nolla-Salas
doaj +1 more source
Immunotherapy and Antifungal Drugs of Candidiasis: Achievements and Challenges
Candida albicans is the most common cause of invasive candidiasis, but in recent years the incidence of infections caused by other species such as Candida Kruzei, Candida glabrata, Candida tropicalis, Candida parapsilosis and Candida lusitania has ...
leili Aghebati-Maleki +3 more
doaj
Invasive candidiasis is a serious and life-threatening disease in thoracic organ transplant recipients. Candida can transition from colonizer to opportunistic pathogen quickly in these hosts.
Emily M. Eichenberger, Stephanie Pouch
doaj +1 more source
Working by a distinct cell wall-specific mechanism of action, the echinocandin class of antifungals has substantially expanded the range of available treatments for invasive Candida infections.
Glöckner A
doaj +1 more source
Background The occurrence of invasive fungal infections in COVID-19 patients is on surge in countries like India. Several reports related to rhino-nasal-sinus mucormycosis in COVID patients have been published in recent times; however, very less has been
Roopak Dubey +5 more
doaj +1 more source
Objectives To investigate the impact of COVID-19 on the burden of hospital-treated Aspergillus and Candida infections in England.Design A retrospective study using Hospital Episodes Statistics data to estimate the burden of serious and invasive fungal ...
Matthew Smith +5 more
doaj +1 more source
Treatment of invasive candidiasis with echinocandins [PDF]
SummaryBlood stream infections by Candida spp. represent the majority of invasive fungal infections in intensive care patients. The high crude mortality of invasive candidiasis remained essentially unchanged during the last two decades despite new treatment options that became available.
Andreas, Glöckner +3 more
openaire +2 more sources
MOESM1 of Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study [PDF]
Additional file 1. Table E1. Characteristics of patients with proven and suspected invasive candidiasis at ICU admission. Table E2. Rate of proven versus suspected invasive candidiasis enrolled by center according to center characteristics.
Didier Guillemot (69521) +13 more
core +1 more source
The assessment of therapeutic response of oropharyngeal and oesophageal candidiasis in AIDS using a new scoring system: studies with D0870. [PDF]
We developed and compared five scoring systems designed to quantitate therapeutic response in cases of oropharyngeal candidiasis. We utilized prospectively collected data on 114 patients treated with several doses of the azole D0870.
Williams, Keith +7 more
core
Background Invasive candidiasis is the most common fungal disease among hospitalized patients and continues to be a major cause of mortality. Risk factors for mortality have been studied previously but rarely developed into a predictive nomogram ...
Ding Li +5 more
doaj +1 more source

